Reliv International Acquires Exclusive Rights to Lunasin
CHESTERFIELD, Jul 24, 2013 --Reliv International, Inc., a maker of nutritional supplements that promote optimal health, today announced that it has entered into an exclusive license for the intellectual property of Soy Labs LLC related to the nutritional ingredient lunasin. Lunasin is a naturally occurring peptide research has identified as the key to many of soy's documented health benefits, from cholesterol reduction to general cellular health.
The license covers an issued patent and several patent applications related to lunasin and soy-related peptides, proprietary information and manufacturing processes of Soy Labs. Further, the arrangement allows certain Soy Labs employees to join the Reliv corporate staff.The License Agreement is for a term covering the entire period of the basic patent and then provides for a full assignment of all of the technology rights to Reliv. Reliv will make minimum payments of 1,150,000 initially and additional minimum payments over a five year period totaling 850,000. In addition, Reliv will pay a royalty at varying rates over the term of the agreement.
"This is a major step for Reliv and elevates our company to a unique status in the nutrition industry," said Ryan Montgomery, Reliv president. "For the first time we own an ingredient in its entirety, from the extraction process to the patented mechanisms of action within the body. And lunasin isn't just any ingredient; it's the world's first epigenetic superfood."
"We've always endeavored to remain on the cutting edge of nutrition science in formulating our products at Reliv. And with the acquisition of lunasin, we are now leading the industry in the budding field of nutritional epigenetics," said Dr. Carl W. Hastings, vice chairman and chief scientific officer.
"New research shows that through nutrition people can influence which genes are expressed," he added. "Reliv is committed to building on this emerging science and developing nutritional solutions that help people take control of their health."
Reliv's license of the intellectual property behind Soy Labs lunasin production and marketing stems from a joint research and development partnership formed in August 2011 among Reliv, Soy Labs and the Missouri Plant Science Center. That partnership resulted in the creation of LunaRich(R) soy powder and LunaRich X(TM), Reliv-exclusive products made from non-GMO soybean varieties with the highest concentration of bioactive lunasin and manufactured through a proprietary mechanical process (vs. chemical) that maintains the lunasin's bioactivity.
Related News
-
Reliv Unveils New LunaRich X Encapsulation Line
CHESTERFIELD, MO, Apr 14, 2015 -- Reliv International, Inc. RELV, a maker of nutritional supplements that promote optimal health, today announced that the company has installed a new state-of-the-art encapsulation line at Reliv headquarters to manufacture LunaRich X(TM), a concentrated lunasin suppl... Read More...Reliv Honored with Two MarCom Awards
November 10, 2014 -- Reliv International, Inc., a maker of nutritional supplements that promote optimal health, today announced that the company has earned two 2014 MarCom Awards for outstanding achievement in marketing communications. Reliv's "How to Make Money with Reliv" video received a Platinum... Read More...Reliv Takes Top Distributors to Quebec City
Annual Leadership Celebration Trip Honors Achievement in 2014CHESTERFIELD, MO , Sep 12, 2014 -- Reliv International, Inc., a maker of nutritional supplements that promote optimal health, today announced that it has sent 67 Reliv Distributors on a four-day incentive trip to Quebec City. The Distri... Read More...Reliv Introduces New LunaRich Super Packs
Chesterfield, MO March 31, 2014 -- Reliv International, Inc., a maker of nutritional supplements that promote optimal health, today announced the launch of the LunaRich® Super Pack, a product package designed to facilitate new customer purchases and new distributor sign-ups. The launch took place th... Read More...
